Letter to the editor
Mutat Res Genet Toxicol Environ Mutagen
.
2022 Apr-May:876-877:503473.
doi: 10.1016/j.mrgentox.2022.503473.
Epub 2022 Feb 16.
Authors
A Zeller
1
,
A Czich
2
,
M Guérard
1
,
N Honarvar
3
,
H-J Martus
4
,
S Pfuhler
5
,
E Vock
6
,
D Kirkland
7
Affiliations
1
F. Hoffmann-La Roche Ltd., Pharmaceutical Sciences, pRED Innovation Center Basel, 4070 Basel, Switzerland.
2
Sanofi, Research and Development, Industriepark Hoechst, 65926 Frankfurt, Germany.
3
BASF SE, Experimental Toxicology and Ecology, Z470, 67056 Ludwigshafen, Germany.
4
Novartis Institutes for BioMedical Research, 4057 Basel, Switzerland.
5
Global Product Stewardship, The Procter & Gamble Company, Cincinnati, OH, USA.
6
Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Strasse 65, 88379 Biberach an der Riss, Germany.
7
Kirkland Consulting, PO Box 79, Tadcaster LS24 0AS, United Kingdom.
PMID:
35483788
DOI:
10.1016/j.mrgentox.2022.503473
No abstract available
Publication types
Letter
Comment